Korrigering till kallelse till årsstämma 2020 i New Nordic Healthbrands AB (publ). I det senaste pressmeddelandet ingick inte information om hur man deltar, den har nu lagts till

Plats: Clarion Hotel & Congress Malmö Live
Adress: Dag Hammarskjölds Torg 2, 211 18 Malmö
Tid: Onsdagen den 29 april 2020 kl. 10.00.



New Nordic Healthbrands AB (publ) - Full Year Report January - December 2019

FULL YEAR 2019

  • Net sales amounted to MSEK 452.6 (393.7), an increase of 15.0 percent. In local currencies, the increase was 10.2 percent.
  • Gross margin decreased to 69.7 percent (70.5).
  • EBITDA increased to MSEK 36.9 (34.9).
  • Operating profit increased to MSEK 36.3 (34.2).
  • Profit after tax for the period increased to MSEK 28.1 (26.5).
  • Earnings per share after tax increased to SEK 4.53 (4.28).

Q4 2019

  • Net sales amounted to MSEK 114.4 (97.6), an increase of 17.2 percent. In local currencies, the increase was 10.9 percent.
  • Gross margin decreased to 67.7 percent (71.7).
  • EBITDA decreased to MSEK 7.1 (10.0).
  • Operating profit decreased to MSEK 7.0 (9.8).
  • Profit after tax for the period decreased to MSEK 4.7 (7.2).
  • Earnings per share after tax decreased to SEK 0.75 (1.17).



New Nordic Healthbrands AB Six month report January - September 2019

NINE MONTHS 2019

  • Net sales amounted to MSEK 338.2 (296.1), an increase of 14.2 percent. In local currencies, the increase was 9.5 percent.
  • Gross margin increased to 70.4 percent (70.1).
  • EBITDA increased to MSEK 29.8 (24.9).
  • Operating profit increased to MSEK 29.3 (24.4).
  • Profit after tax for the period increased to MSEK 23.4 (19.3).
  • Earnings per share after tax increased to SEK 4.81 (4.02).

New Nordic Healthbrands AB Six month report January - July 2019

SIX MONTHS 2019

  • Net sales amounted to MSEK 220.2 (183.4), an increase of 20.1 percent. In local currencies, the increase was 14.2 percent.
  • Gross margin decreased to 70.3 percent (70.5).
  • EBITDA increased to MSEK 15.3 (11.1).
  • Operating profit increased to MSEK 15.0 (10.8).
  • Profit after tax for the period increased to MSEK 12.0 (8.5).
  • Earnings per share after tax increased to SEK 1.94 (1.38).

Q2 2019

  • Net sales amounted to MSEK 116.5 (95.0), an increase of 22.7 percent. In local currencies, the increase was 18.5 percent.
  • Gross margin decreased to 71.0 percent (72.3).
  • EBITDA ioncreased to MSEK 6.8 (3.8).
  • Operating profit increased to MSEK 6.5 (3.6).
  • Profit after tax for the period decreased to MSEK 5.3 (2.9).
  • Earnings per share decreased to SEK 0.85 (0.47).

New Nordic Healthbrands AB (publ) Three Month Report January - March 2019

THREE MONTHS 2019

  • Net sales amounted to MSEK 103.7 (88.4), an increase of 17.3 per cent. In local currencies, the increase was 9.3 per cent.
  • Gross margin increased to 69.5 per cent (68.5).
  • EBITDA increased to MSEK 8.5 (7.3).
  • Operating profit increased to MSEK 8.4 (7.1).
  • Profit after tax for the period increased to MSEK 6.7 (5.6).
  • Earnings per share after tax increased to SEK 1.09 (0.91).

New Nordic Healthbrands AB (publ) Årsredovisning 2018

Årsredovisning 2018 New Nordics årsredovisning är nu tillgänglig på bolagets hemsida https://newnordic.se/se/investor/financial-reports.html 


Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Sturegatan 32
114 36 Stockholm

08-692 21 90
Kontaktformulär